IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
134.5 EUR
-1.6 (-1.18%)
Taking everything into account, IPN scores 6 out of 10 in our fundamental rating. IPN was compared to 54 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year IPN was profitable.
- IPN had a positive operating cash flow in the past year.
- Each year in the past 5 years IPN has been profitable.
- IPN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of 6.56%, IPN perfoms like the industry average, outperforming 54.72% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 10.59%, IPN is in line with its industry, outperforming 52.83% of the companies in the same industry.
- With a decent Return On Invested Capital value of 14.89%, IPN is doing good in the industry, outperforming 75.47% of the companies in the same industry.
- IPN had an Average Return On Invested Capital over the past 3 years of 12.97%. This is in line with the industry average of 13.93%.
- The last Return On Invested Capital (14.89%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.89% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
- The Profit Margin of IPN (11.92%) is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of IPN has declined.
- The Operating Margin of IPN (26.02%) is better than 62.26% of its industry peers.
- IPN's Operating Margin has declined in the last couple of years.
- IPN has a Gross Margin of 83.32%. This is amongst the best in the industry. IPN outperforms 90.57% of its industry peers.
- IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.02% | ||
| PM (TTM) | 11.92% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
- IPN has more shares outstanding than it did 1 year ago.
- IPN has about the same amout of shares outstanding than it did 5 years ago.
- The debt/assets ratio for IPN has been reduced compared to a year ago.
2.2 Solvency
- IPN has an Altman-Z score of 4.73. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 4.73, IPN is doing good in the industry, outperforming 66.04% of the companies in the same industry.
- The Debt to FCF ratio of IPN is 1.46, which is an excellent value as it means it would take IPN, only 1.46 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of IPN (1.46) is better than 90.57% of its industry peers.
- A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
- IPN has a better Debt to Equity ratio (0.20) than 73.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.46 | ||
| Altman-Z | 4.73 |
ROIC/WACC1.9
WACC7.83%
2.3 Liquidity
- IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of IPN (1.98) is better than 69.81% of its industry peers.
- A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
- The Quick ratio of IPN (1.80) is better than 81.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
- IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
- Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
- The Revenue has grown by 9.45% in the past year. This is quite good.
- Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
- Based on estimates for the next years, IPN will show a small growth in Earnings Per Share. The EPS will grow by 5.43% on average per year.
- Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 4.42% on average per year.
EPS Next Y10.08%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPS Next 5Y5.43%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.42%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.10 indicates a correct valuation of IPN.
- Compared to the rest of the industry, the Price/Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 77.36% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of IPN to the average of the S&P500 Index (27.38), we can say IPN is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 12.12, the valuation of IPN can be described as correct.
- Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than 77.36% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, IPN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.1 | ||
| Fwd PE | 12.12 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IPN is valued cheaper than 96.23% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, IPN is valued a bit cheaper than the industry average as 73.58% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.95 | ||
| EV/EBITDA | 6.38 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.3
PEG (5Y)1.49
EPS Next 2Y3.94%
EPS Next 3Y4.55%
5. Dividend
5.1 Amount
- IPN has a Yearly Dividend Yield of 1.03%.
- IPN's Dividend Yield is comparable with the industry average which is at 1.59.
- Compared to an average S&P500 Dividend Yield of 1.85, IPN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
5.2 History
- The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- IPN pays out 25.94% of its income as dividend. This is a sustainable payout ratio.
- The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.94%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPA:IPN (1/16/2026, 7:00:00 PM)
134.5
-1.6 (-1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-12 2026-02-12/amc
Inst Owners15.35%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap11.27B
Revenue(TTM)3.76B
Net Income(TTM)448.00M
Analysts68.89
Price Target131.03 (-2.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.94%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.65%
PT rev (3m)0.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.65%
EPS NY rev (3m)4.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.1 | ||
| Fwd PE | 12.12 | ||
| P/S | 3 | ||
| P/FCF | 18.95 | ||
| P/OCF | 11.54 | ||
| P/B | 2.67 | ||
| P/tB | 8.44 | ||
| EV/EBITDA | 6.38 |
EPS(TTM)10.27
EY7.64%
EPS(NY)11.1
Fwd EY8.25%
FCF(TTM)7.1
FCFY5.28%
OCF(TTM)11.65
OCFY8.66%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.3
PEG (5Y)1.49
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.08% | ||
| ROIC | 14.89% | ||
| ROICexc | 20.47% | ||
| ROICexgc | 77.3% | ||
| OM | 26.02% | ||
| PM (TTM) | 11.92% | ||
| GM | 83.32% | ||
| FCFM | 15.82% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.46 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.61% | ||
| Cap/Sales | 10.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.65% | ||
| Profit Quality | 132.77% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.73 |
F-Score7
WACC7.83%
ROIC/WACC1.9
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y10.08%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPS Next 5Y5.43%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.42%
EBIT growth 1Y66.82%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.49%
FCF growth 1Y-23.46%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-0.85%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
What is the valuation status of IPSEN (IPN.PA) stock?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the financial health of IPSEN (IPN.PA) stock?
The financial health rating of IPSEN (IPN.PA) is 7 / 10.
How sustainable is the dividend of IPSEN (IPN.PA) stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.94%.